Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis

J Allergy Clin Immunol. 2008 Aug;122(2):425-7. doi: 10.1016/j.jaci.2008.06.012.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Eosinophils* / cytology
  • Eosinophils* / drug effects
  • Eosinophils* / immunology
  • Epithelial Cells / cytology
  • Epithelial Cells / immunology
  • Epithelial Cells / metabolism
  • Esophagitis / drug therapy*
  • Esophagitis / immunology
  • Esophagitis / pathology
  • Esophagus / immunology
  • Esophagus / pathology
  • Humans
  • Infliximab
  • Leukocyte Count
  • Male
  • Pilot Projects
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / immunology*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha
  • Infliximab